Showing results (1161-1170 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|November 1, 1989
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, M Rettenmaier, et al.Investigational New Drugs|January 1, 1985
Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON)A Rahman, F P Smith, P T Luc, et al.Investigational New Drugs|December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor modelsZ Zylicz, D J Wagener, H van Rennes, et al.Investigational New Drugs|December 1, 1988
Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancerP Herait, P Rougier, J Oliveira, et al.Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.Investigational New Drugs|January 1, 1984
Phase II study of carminomycin in a human tumor cloning assayM Rozencweig, C Sanders, W Rombaut, et al.Investigational New Drugs|January 1, 1984
Phase I study with 4'-deoxydoxorubicinL Ferrari, A Rossi, C Brambilla, et al.Investigational New Drugs|January 1, 1984
Phase I evaluation of AT-125 single dose every three weeksS Taylor, R J Belt, U Joseph, et al.Investigational New Drugs|August 20, 2016
Comprehensive analysis of clinical development and regulatory submission promotion schemes for oncologic drugs as the Japanese national projectsSumimasa Nagai, Keiya OzawaInvestigational New Drugs|July 21, 2015
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancerBengt Gustavsson, Göran Carlsson, Torbjörn Swartling, et al.Pageof 372